The psychedelics and cannabis sectors share a lot of similarities – is profit potential one of them? Here’s what to know…

Over the past year, we’ve watched psychedelics transform from a fringe sector of holistic medicine to a legitimate pharmaceutical industry backed by venture capital heavyweights like Peter Thiel.

Thiel, the legendary billionaire entrepreneur, helped launch German psychedelics startup Atai Life Sciences (Nasdaq: ATAI) onto the world stage earlier this year – making it the third psychedelics company to IPO on a major exchange.

And it won’t be the last.

These companies are tapping into ancient psychedelic compounds whose therapeutic applications are only now being clinically applied to treat debilitating conditions like depression, anxiety, PTSD, and addiction.

And much like with cannabis, as the research surrounding these drugs rapidly develops, we’re realizing that their healing capabilities are groundbreaking…

Groundbreaking enough to potentially create a $10.7 billion psychedelics market by 2028.

Over the past few months, I’ve given you an inside look at this emerging market and shared exclusive one-on-one interviews with some of its biggest players.

We’ve seen the former pure-play cannabis company Vireo Health International Inc. enter the psychedelics space and emerge as Goodness Growth Holdings Inc. (OTC: GDNSF).

Our Cannabis Inner Circle subscribers were even able to take a profit on industry leader Cybin Inc. (NYSE: CYBN) in July.

But we’re still in the very early phases of this opportunity, and there’s a lot to learn.

To find out whether the psychedelics market has as much profit potential as cannabis, I connected with Advisory Board Member Charles Delvalle for another episode of Underrated or Overrated?

And – spoiler alert – we had some disagreements.

Tune in now for a sneak peek into the emerging opportunities in the psychedelics sector and the profits at stake for cannabis investors…

[NEW] NICI Membership subscribers have received two new trade recommendations in the last week, including this sell that dropped just hours ago. You can join them and never miss another real-time profit alert – plus gain access over a dozen of our best cannabis stock picks and trade recommendations – by clicking here.

To your investing success,

Danny Brody
Executive Director, National Institute for Cannabis Investors


Leave a Reply

Your email address will not be published. Required fields are marked *